← FDA Drug Approvals (Drugs@FDA)
LIQREV
NDA · New Drug Application · Sponsor: CMP DEV LLC · Approved 2023-04-28
Drug application
- FDA Application #
NDA214952- Application type
- New Drug Application
- Brand name
- LIQREV
- Generic name
- Sildenafil Citrate
- Active ingredients
- SILDENAFIL CITRATE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CMP DEV LLC
- First approval
- 2023-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown